Institution statistics

CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH - Austria 

This institution has been merged with: CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GES M B H.

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:> 1000
Networking Rank (Reputation):600-700
2016
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:200-300
Total Number of Projects:600-700
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 25
As coordinator: 1
As participant: 11
Sole participant: 13
Coordinator / Participant Ratio: 0.09*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 1.331.340 18.947.299 1.831.055 1 2
2018 13.980.916 0 8.821.927 2
2016 5.550.155 146.668 5.696.823 4 1
2015 178.157 2.291.641 356.362 1 1
2013 280.191 1.497.982 1.778.173 2 1
2012 100.000 150.000 250.000 1 1
2011 100.000 33.266.366 1.009.709 1 2
2010 0 17.673.179 2.983.916 3
2008 397.626 0 397.626 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
INSTITUT CURIE3
UNIVERSITY OF COPENHAGEN3
ACADEMISCH ZIEKENHUIS GRONINGEN2
CELLZOME2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
ISTITUTO EUROPEO DI ONCOLOGIA2
RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE BABRAHAM INSTITUTE2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITAETSKLINIKUM ESSEN2
UNIVERSITY COLLEGE LONDON2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
WEIZMANN INSTITUTE OF SCIENCE2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGILENT TECHNOLOGIES OESTERREICH1
ASSEMBLEA DELLE DONNE PER LO SVILUPPO E LA LOTTA ALL'ESCLUSIONE SOCIALE ASDO1
AXXAM1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BAYER1
BAYER AKTIENGESELLSCHAFT1
BAYER SCHWEIZ1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIOMERIEUX1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORZIO INTERDISCIPLINARE DI STUDI BIOMOLECOLARI ED APPLICAZIONI INDUSTRIALI SCRL1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIAGENODE1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELLINIKO INSTITUTO MELETIS TIS SIPSIS1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN RESEARCH AND PROJECT OFFICE1
FORSCHUNGSVERBUND BERLIN EV1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION1
FUNDACIO CENTRE DE REGULACIO GENOMICA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA1
GENOMATIX SOFTWARE1
GENOME RESEARCH1
HALO GENOMICS AB1
HELMHOLTZ ZENTRUM BERLIN FUER MATERIALIEN UND ENERGIE1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HOSPICES CIVILS DE LYON1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTUL DE CHIMIE TIMISOARA AL ACADEMIEI ROMANE1
INSTYTUT BIOLOGII MEDYCZNEJ POLSKIEJ AKADEMII NAUK1
IRBM SCIENCE PARK1
LUNDS UNIVERSITET1
MAGYAR TUDOMANYOS AKADEMIA TERMESZETTUDOMANYI KUTATOKOZPONT1
MASARYKOVA UNIVERZITA1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZGEMEINSCHAFT1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE UNIVERSITAET WIEN1
NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""1
NERVIANO MEDICAL SCIENCES1
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
NOVARTIS PHARMA1
OXFORD NANOPORE TECHNOLOGIES1
PFIZER LIMITED1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI1
SIENA BIOTECH1
SIGOLIS AB1
SOURCE BIOSCIENCE PLC1
ST ANNA KINDERKREBSFORSCHUNG1
TEL AVIV UNIVERSITY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
THE UNIVERSITY OF WARWICK1
UMEA UNIVERSITET1
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA1
UNIVERSITAET BERN1
UNIVERSITAET DES SAARLANDES1
UNIVERSITAET LEIPZIG1
UNIVERSITAET ULM1
UNIVERSITAETSKLINIKUM JENA1
UNIVERSITAT WIEN1
UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJNAPOCA1
Constancy:

Total number of partners:134

Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 125

Frequent / Rare Partner Ratio: 0.07

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES8
RTD HORIZONTAL TOPICS7
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-03-01Dna Damage REsponse: Actionabilities, Maps and Mechanisms DDREAMMparticipant8.865.9654
2020-01-01Personalized immunotherapy in sepsis: a precision medicine based approach ImmunoSepparticipant10.081.33414
2020-01-01Therapeutic hijacking of E3 Ligases Glue2Degradecoordinator1.331.3401
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEcoordinator12.000.00014
2018-05-01Chromatin-localized central metabolism regulating gene expression and cell identity CHROMABOLISMcoordinator1.980.9161
2016-12-01An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell EpigenomeProgrammingcoordinator1.281.2051
2016-10-01Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials chemosparticipant146.6681
2016-10-01Solute carrier proteins as the gates managing chemical access to cells GameofGatescoordinator2.389.7821
2016-07-01Synthetic Lethal Interactions with nucleophosMin 1 SLIMcoordinator178.1571
2016-04-01Crosstalk of Metabolism and Inflammation CMILcoordinator1.701.0111
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-05-01Solute carrier proteins and the uptake of cytotoxic approved drugs DrugsUPcoordinator178.1571
2013-12-20A proteomic screen to identify cytoplasmic DNA sensor proteins mediating type I Interferon production INNATEDNASENSORcoordinator180.1911
2013-07-01BERG – Biomedical Epigenomics Research Group BERGcoordinator100.0001
2013-05-01Discovering Gene-Drug Interactions in Breast Cancer With a Systematic and Genetically Tractable Model "GENES, DRUGS AND BRparticipant1.497.9821
2012-12-01Acute Inflammation Resolution by Soluble Human Inhibitory Protein AIRSHIPparticipant150.0001
2012-09-01DNA damage response: ATMIN regulated non-canonical ATM activation NONCANATMcoordinator100.0001
2011-12-01Systematic Identification and Validation of Epigenetic Cancer Lesions by Chemical Biology and Functional Genomics EPICALcoordinator100.0001
2011-11-01HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis HEM_IDparticipant3.269.70212
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-11-01European Infrastructure of Open Screening Platforms for Chemical Biology EU-OPENSCREENparticipant3.700.00023
2010-04-01Interferon-focused Innate Immunity Interactome and Inhibitome i-FIVEparticipant1.974.0221
2008-08-01Small molecule antagonists of chromatin modifying enzymes for regulation of transcription, proliferation and differentiation SMARTcoordinator229.6661
2008-08-01Dissecting pathogen recognition complexes of Toll-like receptors: hunting for new co-receptors and ligands TOLLICORcoordinator167.9601
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum